Latest news
Can We Make Stage IV Lung Cancer Curable? New Research Offers Hope - Targeted OncologyTargeted Oncology · Sat, 08 Aug 2026 18:00:00 GMTUH Researcher Awarded NIH R01 Grant to Advance Precision Immunotherapy for Lung Cancer - John A. Burns School of MedicineJohn A. Burns School of Medicine · Sat, 08 Aug 2026 04:10:12 GMTDr Patt Reflects on the Evolution of ePRO Monitoring - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 22:11:35 GMTePRO Monitoring: Earlier Intervention, Fewer Hospitalizations - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 22:00:00 GMTCan Doctors Predict Who Immunotherapy Will Work For? City of Hope Aims to Find Out - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 17:59:40 GMTAge May Inform Risk Stratification in Alcohol-Related HCC - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 16:35:34 GMTFDA Approves Oncolytic Viral Therapy With Immunotherapy for Advanced Melanoma - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 14:44:33 GMTFDA approves Replimmune’s immunotherapy for advanced melanoma - PharmaLivePharmaLive · Fri, 07 Aug 2026 13:02:22 GMT